Vol.
39
No.
24
June 14, 2013Jun 14, 2013

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

FASEB: Focus on Research Funding, Not PR

MD Anderson Researcher Charged With Placing Ethylene Glycol In Colleague’s Coffee

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.

Login